
Long-Acting Drug Market Projected to Hit US$ 13.3 Billion by 2033
The global market for long-acting therapeutics is set for significant expansion, with valuations expected to climb from US$ 7.2 billion in 2026 to US$ 13.3 billion by 2033. This growth, driven by an 8.9% annual compound rate, reflects a shift toward patient-friendly dosing for chronic conditions like diabetes and cancer.

















:max_bytes(150000):strip_icc()/blue-power-meters-161049597-58ae35b05f9b58a3c9346a59.jpg)





:max_bytes(150000):strip_icc():focal(746x298:748x300)/aki-koichi-daily-outfits-050124-1-38a52b142f0b43f9b3c25ce3799bb182.jpg)


